Articles related to CONTRACEPTION/BIRTH CONTROL

The new guideline emphasizes early intervention and careful medication selection for pregnant patients with epilepsy, recommending lamotrigine, levetiracetam, and oxcarbazepine, while advising against valproic acid, phenobarbital, and topiramate.

In the case of Emily Westerfield, surrogacy practices come into question as she approaches her 11th pregnancy, far beyond the recommended guidelines, raising significant concerns about the health risks and ethical dimensions of surrogacy.

This study at UT Southwestern shows that vaginal misoprostol could reduce the oxytocin requirement in labor induction, enhancing care efficiency without compromising patient safety.

This incident at Bulovka University Hospital serves as a poignant reminder of the consequences of neglecting established patient safety protocols, particularly the crucial role of effective communication and stringent patient identification in preventing medical errors.

Physicians should be vigilant about the dual impact of GLP-1 drugs on contraceptive failure and unexpected fertility enhancements, prompting a reassessment of patient guidance and contraceptive choices in clinical practice.

This study underscores the complexity of prescribing antiseizure medications during pregnancy, revealing that while topiramate and lamotrigine show no significant increase in autism spectrum disorder risk post-adjustment, valproate exposure remains a concern due to its association with a higher ASD incidence.